Associated Papers
PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy.
Cho YA et al.
Current Oncology (toronto, Ont.), 2022
35621626 (PubMed )
Supplement: curroncol-29-00236-s001.zip › curroncol-1656685-supplementary.pdf
NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing.
Chang PY et al.
Oncotarget, 2016
Select a paper to view details